Tongli Pharmaceuticals | Balance Sheet
Fiscal year is April-March. All values USD Thousands.
2009
2010
2011
2012
2013
Cash & Short Term Investments
50.20
30.10
592.70
23.50
80.60
Total Accounts Receivable
1,381.50
1,817.70
2,060.80
4,253.70
2,966.40
Inventories
19.00
109.40
194.10
3,203.10
432.80
Other Current Assets
-
3.90
1,131.20
1,657.10
589.80
Total Current Assets
1,450.70
1,961.10
3,978.60
9,137.40
4,069.70
Net Property, Plant & Equipment
7,076.70
6,744.40
6,383.70
6,193.50
5,952.70
Total Investments and Advances
-
-
3,359.50
-
-
Intangible Assets
-
163.20
4,144.90
4,041.00
3,277.00
Other Assets
1,028.70
2,641.40
-
469.70
8,760.70
Total Assets
9,556.20
11,510.10
17,866.80
19,841.70
22,060.00
ST Debt & Current Portion LT Debt
1,043.00
788.20
-
-
261.20
Accounts Payable
119.60
101.60
756.40
429.10
355.40
Income Tax Payable
-
-
834.90
879.40
-
Other Current Liabilities
563.50
556.00
199.50
192.30
976.30
Total Current Liabilities
1,726.20
1,445.70
1,790.80
1,500.80
1,592.90
Long-Term Debt
-
-
1,072.10
-
-
Total Liabilities
1,726.20
1,445.70
2,862.80
1,500.80
1,592.90
Common Equity (Total)
7,830.00
10,064.30
15,003.90
18,340.80
20,467.20
Total Shareholders' Equity
7,830.00
10,064.30
15,003.90
18,340.80
20,467.20
Total Equity
7,830.00
10,064.30
15,003.90
18,340.80
20,467.20
Liabilities & Shareholders' Equity
9,556.20
11,510.10
17,866.80
19,841.70
22,060.00
About Tongli Pharmaceuticals
View Profile
